Cargando…
Patient–doctor relationship and adherence to capecitabine in outpatients of a German comprehensive cancer center
PURPOSE: The prescribing of oral chemotherapy agents has introduced the new challenge of ensuring patients’ adherence to therapy. Aspects of a close patient–doctor relationship are reported to be correlated with adherence to oral anticancer drugs, but data on capecitabine are scarce. PATIENTS AND ME...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6159803/ https://www.ncbi.nlm.nih.gov/pubmed/30288028 http://dx.doi.org/10.2147/PPA.S169354 |
_version_ | 1783358660410343424 |
---|---|
author | Hefner, Jochen Berberich, Sara Lanvers, Elena Sanning, Maria Steimer, Ann-Kathrin Kunzmann, Volker |
author_facet | Hefner, Jochen Berberich, Sara Lanvers, Elena Sanning, Maria Steimer, Ann-Kathrin Kunzmann, Volker |
author_sort | Hefner, Jochen |
collection | PubMed |
description | PURPOSE: The prescribing of oral chemotherapy agents has introduced the new challenge of ensuring patients’ adherence to therapy. Aspects of a close patient–doctor relationship are reported to be correlated with adherence to oral anticancer drugs, but data on capecitabine are scarce. PATIENTS AND METHODS: Sixty-four outpatients with a diagnosis of cancer and prescribed capecitabine were recruited from a German Comprehensive Cancer Center. We used the Patient–Doctor Relationship Questionnaire (PDRQ-9), the Medical Adherence Rating Scale (MARS), the Beliefs about Medicines Questionnaire (BMQ), and the Satisfaction with Information about Medicines Scale (SIMS) to assess patients’ perceptions and behavior. Medical data were extracted from the charts. RESULTS: Non-adherence was reported by 20% of the 64 participants. The perceived quality of the patient–doctor relationship was high in general, but it did not emerge as a predictor of adherence in our survey (odds ratio [OR]=0.915, P=0.162, 95% CI=0.808–1.036). However, beliefs about medicine (OR=1.268, P<0.002; 95% CI=1.090–1.475) as well as satisfaction with information about medicine (OR=1.252, P<0.040, 95% CI=1.010–1.551) were predictors of adherence and the quality of the patient–doctor relationship was correlated with both variables (r=0.373, P=0.002 for SIMS sum score; r=0.263, P=0.036 for BMQ necessity/concern difference). Overall, adherence to capecitabine was high with a conviction that the therapy is necessary. However, concerns were expressed regarding the long-term effect of capecitabine use. Patients have unmet information needs regarding interactions of capecitabine with other medicines and the impairment of their intimate life. CONCLUSIONS: In order to ensure adherence to capecitabine, our results seem to encourage the default use of modern and perhaps more impersonal means of information brokerage (eg, email, internet). However, the contents of some of patients’ informational needs as well as the associations of patients’ beliefs and satisfaction about the information received suggest a benefit from a trustful patient–doctor relationship. |
format | Online Article Text |
id | pubmed-6159803 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-61598032018-10-04 Patient–doctor relationship and adherence to capecitabine in outpatients of a German comprehensive cancer center Hefner, Jochen Berberich, Sara Lanvers, Elena Sanning, Maria Steimer, Ann-Kathrin Kunzmann, Volker Patient Prefer Adherence Original Research PURPOSE: The prescribing of oral chemotherapy agents has introduced the new challenge of ensuring patients’ adherence to therapy. Aspects of a close patient–doctor relationship are reported to be correlated with adherence to oral anticancer drugs, but data on capecitabine are scarce. PATIENTS AND METHODS: Sixty-four outpatients with a diagnosis of cancer and prescribed capecitabine were recruited from a German Comprehensive Cancer Center. We used the Patient–Doctor Relationship Questionnaire (PDRQ-9), the Medical Adherence Rating Scale (MARS), the Beliefs about Medicines Questionnaire (BMQ), and the Satisfaction with Information about Medicines Scale (SIMS) to assess patients’ perceptions and behavior. Medical data were extracted from the charts. RESULTS: Non-adherence was reported by 20% of the 64 participants. The perceived quality of the patient–doctor relationship was high in general, but it did not emerge as a predictor of adherence in our survey (odds ratio [OR]=0.915, P=0.162, 95% CI=0.808–1.036). However, beliefs about medicine (OR=1.268, P<0.002; 95% CI=1.090–1.475) as well as satisfaction with information about medicine (OR=1.252, P<0.040, 95% CI=1.010–1.551) were predictors of adherence and the quality of the patient–doctor relationship was correlated with both variables (r=0.373, P=0.002 for SIMS sum score; r=0.263, P=0.036 for BMQ necessity/concern difference). Overall, adherence to capecitabine was high with a conviction that the therapy is necessary. However, concerns were expressed regarding the long-term effect of capecitabine use. Patients have unmet information needs regarding interactions of capecitabine with other medicines and the impairment of their intimate life. CONCLUSIONS: In order to ensure adherence to capecitabine, our results seem to encourage the default use of modern and perhaps more impersonal means of information brokerage (eg, email, internet). However, the contents of some of patients’ informational needs as well as the associations of patients’ beliefs and satisfaction about the information received suggest a benefit from a trustful patient–doctor relationship. Dove Medical Press 2018-09-21 /pmc/articles/PMC6159803/ /pubmed/30288028 http://dx.doi.org/10.2147/PPA.S169354 Text en © 2018 Hefner et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Hefner, Jochen Berberich, Sara Lanvers, Elena Sanning, Maria Steimer, Ann-Kathrin Kunzmann, Volker Patient–doctor relationship and adherence to capecitabine in outpatients of a German comprehensive cancer center |
title | Patient–doctor relationship and adherence to capecitabine in outpatients of a German comprehensive cancer center |
title_full | Patient–doctor relationship and adherence to capecitabine in outpatients of a German comprehensive cancer center |
title_fullStr | Patient–doctor relationship and adherence to capecitabine in outpatients of a German comprehensive cancer center |
title_full_unstemmed | Patient–doctor relationship and adherence to capecitabine in outpatients of a German comprehensive cancer center |
title_short | Patient–doctor relationship and adherence to capecitabine in outpatients of a German comprehensive cancer center |
title_sort | patient–doctor relationship and adherence to capecitabine in outpatients of a german comprehensive cancer center |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6159803/ https://www.ncbi.nlm.nih.gov/pubmed/30288028 http://dx.doi.org/10.2147/PPA.S169354 |
work_keys_str_mv | AT hefnerjochen patientdoctorrelationshipandadherencetocapecitabineinoutpatientsofagermancomprehensivecancercenter AT berberichsara patientdoctorrelationshipandadherencetocapecitabineinoutpatientsofagermancomprehensivecancercenter AT lanverselena patientdoctorrelationshipandadherencetocapecitabineinoutpatientsofagermancomprehensivecancercenter AT sanningmaria patientdoctorrelationshipandadherencetocapecitabineinoutpatientsofagermancomprehensivecancercenter AT steimerannkathrin patientdoctorrelationshipandadherencetocapecitabineinoutpatientsofagermancomprehensivecancercenter AT kunzmannvolker patientdoctorrelationshipandadherencetocapecitabineinoutpatientsofagermancomprehensivecancercenter |